Suppose Novo Nordisk sues Hims & Hers and the judge affirms that Hims & Hers acts within the law, which I still think is likely, it would be a total disaster for Novo Nordisk
Many factors can contribute to blood clots, such as underlying health conditions, lifestyle choices, and other medications
There are two separate questions at stake, Feldman said
Tirzepatide is unique because it is a dual agonistit mimics two natural hormones in your body: One of the primary ways GLP-1 medications help you lose weight is by physically slowing down your digestion
[5] Wegovy, which is prescribed solely for weight loss, is much less commonly covered by insurance companies, mainly because covering weight loss drugs is extremely expensive due to the number of qualifying patients
Cosmos Study September 9, 2025 Dual-Team Study Team A:Kersten Bartelt, RNJoe Deckert, PhD Team B:Blaine Franklin, PT, DPTEric Barkley Key Findings At 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight
